Clinical Trials List
2013-09-01 - 2017-03-10
Phase III
Terminated13
ICD-10E11.21
Type 2 diabetes mellitus with diabetic nephropathy
ICD-10E11.22
Type 2 diabetes mellitus with diabetic chronic kidney disease
ICD-10E11.29
Type 2 diabetes mellitus with other diabetic kidney complication
ICD-10E13.21
Other specified diabetes mellitus with diabetic nephropathy
ICD-10E13.22
Other specified diabetes mellitus with diabetic chronic kidney disease
ICD-10E13.29
Other specified diabetes mellitus with other diabetic kidney complication
ICD-9250.40
Diabetes with renal manifestations, Type II [non-insulin dependent type][NIDDM type][adult-onset type] or unspecified type ,not stated as uncontrolled
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
165 participants
-
Global
4148 participants
